7 | $JSPR hod2.85 @2.18 S2? or | znewcar1 | 01/13/2023 12:26:35 PM |
6 | $JSPR 467% v60,9M c2.74 f37,073M H3.80 ML.39 | znewcar1 | 01/03/2023 4:13:54 PM |
5 | JSPR 23% v326K c3.77 f37,8M | znewcar1 | 05/02/2022 9:35:06 PM |
4 | JSPR 17% v1,3M c9.99 f37,8M | znewcar1 | 12/09/2021 9:51:08 PM |
3 | JSPR 31% v35,7M c16.42 f36,5M | znewcar1 | 10/17/2021 10:39:31 PM |
2 | morning gap up and fade now has vol | znewcar1 | 10/15/2021 3:21:25 PM |
1 | JSPR 105% v91,7M c14.79 f36,5M | znewcar1 | 10/13/2021 4:05:29 PM |
Recent Articles
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025
- Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
- Max Stock Limited Reveals Holdings of Key Parties and Officers
- China's Revolutionary Advances in Solid-State Battery Tech
- Biggest Weekly Losers: Insights on IonQ and Tempus AI Stocks
- Revolutionizing Startup Insight with AI: Startuprad.io's New Tool
- Revolutionizing Patient Care with AI: HDAI's Innovative Approach
- Top Gainers in the Market: D-Wave, Estée Lauder & Others
- Empowering Higher Education Payroll Professionals at EIPC
- SystImmune's Iza-bren Shows Promising Results in Cancer Trial
- Latest Developments in the Auto Industry and Technology Advancements
- RAPT Therapeutics Set to Unveil Key Clinical Findings Soon
- Tech Industry Update: Innovations, Earnings, and Future Trends
- Mutuum Finance Advances Plans for Testnet Launch in 2025
- Replimune Showcases Promising Results for Acral Melanoma
- Exciting Developments in RAPT Therapeutics' Clinical Trials
- Are Aliens Now More Likely Than Bitcoin Reaching $200,000?
- Apple's New F1 Streaming Deal and Exciting Recent Developments
- World Winter Sports Expo 2025: A New Era for the Industry
- Alibaba Cloud Revolutionizes AI with Aegaeon System Efficiency
- Mint Miner Innovates with AI-Powered Cloud Mining Solutions
- China Raises Alarms About US Cyberattacks on Key Services